Specific Biologics Inc. ("Specific"), a biotechnology company developing industry-leading in vivo genome editing medicines to treat the untreatable, today announced that together with Western ...

Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

The simulator takes into account forecasted demand in each region, transportation costs, and the operational capacity of each warehouse.

Researchers at the European Molecular Biology Laboratory (EMBL) in Germany have unveiled an artificial intelligence system designed to ...

AI in life sciences presents key opportunities in drug discovery, personalized medicine, and diagnostics by leveraging vast datasets for precise, cost-effective solutions. Growth is driven by ...

An interdisciplinary research team from two working groups at the Center for Synthetic Biology at TU Darmstadt has developed ...

A powerful new real-world data platform could transform how scientists predict and understand Alzheimer’s disease and Alzheimer’s disease related dementias (AD/ADRD), reports a new study at Columbia ...

In most boardrooms, the final decision still comes down to a small circle of leaders weighing a narrow set of choices. Yet the problems they face now contain thousands, sometimes millions, of possible ...

After an unexpected, late-session veto, the effort to strengthen protections for consumer health information is back on the table in New York.

How can cells be programmed to respond to complex signals and make targeted decisions, similar to a logical circuit in a computer? Researchers have developed a new approach: an RNA-based genetic ...

This article explores how multiomics integration, imaging, and bioinformatics are advancing biomarker discovery, revealing ...

A powerful new real-world data platform could transform how scientists predict and understand Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD), reports a new study at Columbia ...